Stage Iib Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-08-19
Clinical Trial Update: Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) [Phase 3]
Phase 3 clinical trial investigating elacestrant for estrogen receptor-positive, HER2-negative breast cancer with ctDNA relapse (TREAT ctDNA…